Table 3 A cross-study comparison of long term survival data and early death rates of the patients with HNSCC from Basel and patients with HNSCC who had been treated within published clinical trials with concurrent chemo-radiotherapy

Bonner et. al.

2006

55

40*

11/211 (5%)

Huguenin et. al.

2004

59°

46

0/112 (0%)

Calais et. al.

1999

51

-

1/109 (1%)

Merlano et. al.

1996

38*

24

not reported

Adelstein et. al.

2000

37

28*

6/96 (6%)

Wendt et. al.

1998

49

-

4/256 (2%)

Brizel et. al.

1998

55

48*

1/56 (2%)

Al-Sarraf et. al.

1998

78

68*

1/78 (1%)

Data from Basel

1994-2007

54

47

9/167 (5%)

- Therapy before 2000

43

33

- Therapy after 2000

65

61